Literature DB >> 5129727

Purification and properties of carboxypeptidase G 1 .

J L McCullough, B A Chabner, J R Bertino.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5129727

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  26 in total

1.  Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate.

Authors:  John J McGuire; David M Bartley; John W Tomsho; William H Haile; James K Coward
Journal:  Arch Biochem Biophys       Date:  2009-06-27       Impact factor: 4.013

2.  Enhanced plasma persistence of therapeutic enzymes by coupling to soluble dextran.

Authors:  R F Sherwood; J K Baird; T Atkinson; C N Wiblin; D A Rutter; D C Ellwood
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

3.  Carboxypeptidase displaying differential velocity in hydrolysis of methotrexate, 5-methyltetrahydrofolic acid, and leucovorin.

Authors:  A M Albrecht; E Boldizsar; D J Hutchison
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

4.  Purification and properties of cytidine deaminase from normal and leukemic granulocytes.

Authors:  B A Chabner; D G Johns; C N Coleman; J C Drake; W H Evans
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

5.  Specificity of the carboxypeptidase inhibitor from potatoes.

Authors:  G M Hass; S P Ager; D Le Tourneau; J E Derr-Makus
Journal:  Plant Physiol       Date:  1981-04       Impact factor: 8.340

6.  Sensitive luciferin derived probes for selective carboxypeptidase activity.

Authors:  Yu-Cheng Chang; Pei-Wen Chao; Ching-Hsuan Tung
Journal:  Bioorg Med Chem Lett       Date:  2011-05-14       Impact factor: 2.823

7.  Anisotropic membranes with carboxypeptidase G1.

Authors:  A M Pitt; S M Cramer; A B Czernicki; K Kalghatgi; C Horvath; B A Solomon
Journal:  Appl Biochem Biotechnol       Date:  1983-02       Impact factor: 2.926

8.  Pharmacokinetic characterization of extracorporeal therapy.

Authors:  H Pedersen; C Horváth
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

9.  Structural role of the polyglutamate portion of the folate found in T4D bacteriophage baseplate.

Authors:  L M Kozloff; L K Crosby; C M Baugh
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

10.  Formation of 10-formylfolic acid, a potent inhibitor of dihydrofolate reductase, in rat liver slices incubated with folic acid.

Authors:  M D'Urso-Scott; J Uhoch; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.